10.07.2017 • NewsDede WillamsIneosoxochimie

Ineos may Produce Oxo Derivatives

(c) https://twitter.com/ineos
(c) https://twitter.com/ineos

After acquiring Arkema’s 50% share in the Oxochimie joint venture, Ineos Oxide, a subsidiary of Swiss-based olefins and polyolefins giant Ineos, said it has completed a strategic review of the business and is considering entering oxo derivatives production.

Ineos said it  has decided to proceed with an engineering study into the production of an array of oxo chemical derivatives, including 2-ethyl hexanoic acid and polyalcohols, such as trimethylolpropane (TMP) and neopentyl glycol (NPG).

Possible locations for a production facility include Ineos group sites at Zwijndrecht, Belgium and Dormagen, Germany,  or a co-location with the existing oxo alcohol plant in Lavéra, France.

Graham Beesley, CEO of Ineos Oxide, said the company is pleased with the speed at which Oxochimie has been fully integrated and is now looking for the “logical next step” to grow the business. The range of products it may manufacture will complement its existing products for the coatings and lubricants markets.

Oxochimie is regarded as one of Europe’s leading producers of the petrochemical raw materials n-butanol, 2-ethylhexanol, isobutanol, n-butyraldehyde and isobutyraldehyde.

The French specialty chemicals producer uses part of the Lavera output as a feedstock for its European acrylic esters production. The remaining volumes are sold on the free market, As sole owner of Oxochimie, Ineos will continue to supply Arkema’s acrylic esters production.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.